CytoLogic's Seed Round

CytoLogic raised a round of funding on June 17, 2012.

CytoLogic is an early-stage medical device company focused on developing technology for treating cancerous tumors. The company's UNLEASH therapy, which involves selective filtration of blood plasma on…

Articles about CytoLogic's Seed Round: